Abstract
The metastatic melanoma is resistant to therapies with high recurrence rates, giving the patient a very poor prognosis. The precise cause of therapeutic resistance in melanoma is still unknown and some mechanisms are proposed, including: mechanism of multi-drug resistance (MDR), overexpression of inhibitors of apoptosis, altered gene expression and induction of pathways and cell survival …